Ontology highlight
ABSTRACT: Background
The angelic acid moiety represents an essential modification in many biologically active products. These products are commonly known as angelates and several studies have demonstrated their therapeutic benefits, including anti-inflammatory and anti-cancer effects. However, their availability for use in the development of therapeutics is limited due to poor extraction yields. Chemical synthesis has been achieved but its complexity prevents application, therefore microbial production may offer a promising alternative. Here, we engineered the budding yeast Saccharomyces cerevisiae to produce angelyl-CoA, the CoA-activated form of angelic acid.Results
For yeast-based production of angelyl-CoA we first expressed genes recently identified in the biosynthetic cluster ss
SUBMITTER: Callari R
PROVIDER: S-EPMC5948907 | biostudies-literature | 2018 May
REPOSITORIES: biostudies-literature